Laura Deming
Partner, The Longevity Fund

Currently a Forbes 30 under 30 star and partner at the Longevity Fund, Laura Deming has wanted to cure aging since the age of eight. After years working on nematode longevity at the UCSF graduate school, Laura matriculated at MIT at 14 to work on artificial organogenesis and bone aging. She is now based in San Francisco, working to find and fund therapies to extend the human health span. She has also recently become a Board Observer at Navitor Pharmaceuticals.